6.35
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.31
Aprire:
$6.48
Volume 24 ore:
867.96K
Relative Volume:
0.46
Capitalizzazione di mercato:
$478.59M
Reddito:
$11.40B
Utile/perdita netta:
$-95.73M
Rapporto P/E:
-2.5918
EPS:
-2.45
Flusso di cassa netto:
$-64.37M
1 W Prestazione:
-7.03%
1M Prestazione:
-35.79%
6M Prestazione:
-1.55%
1 anno Prestazione:
-21.99%
Mind Medicine Inc Stock (MNMD) Company Profile
Nome
Mind Medicine Inc
Settore
Industria
Telefono
212-220-6633
Indirizzo
ONE WORLD TRADE CENTER, NEW YORK
Confronta MNMD con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MNMD
Mind Medicine Inc
|
6.35 | 478.59M | 11.40B | -95.73M | -64.37M | -2.45 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
504.77 | 129.62B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
666.87 | 72.91B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
604.96 | 36.76B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
241.76 | 31.30B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
259.19 | 27.86B | 3.32B | -860.46M | -1.04B | -8.32 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-01-28 | Iniziato | Evercore ISI | Outperform |
2024-12-20 | Iniziato | Chardan Capital Markets | Buy |
2024-10-14 | Ripresa | Leerink Partners | Outperform |
2024-07-24 | Iniziato | ROTH MKM | Buy |
2024-05-29 | Iniziato | Robert W. Baird | Outperform |
2024-04-15 | Iniziato | Leerink Partners | Outperform |
2023-12-05 | Iniziato | Canaccord Genuity | Buy |
2022-12-09 | Ripresa | ROTH Capital | Buy |
2022-11-16 | Iniziato | RBC Capital Mkts | Outperform |
2022-08-26 | Iniziato | Oppenheimer | Outperform |
2022-08-10 | Iniziato | Cantor Fitzgerald | Overweight |
2022-05-04 | Iniziato | ROTH Capital | Buy |
2021-06-28 | Iniziato | Maxim Group | Buy |
Mostra tutto
Mind Medicine Inc Borsa (MNMD) Ultime notizie
MindMed’s SWOT analysis: psychedelic stock’s journey through mental health market - Investing.com
MindMed at Leerink’s Global Healthcare Conference: Strategic Insights on Psychedelics - Investing.com India
What is HC Wainwright’s Estimate for MNMD FY2029 Earnings? - Defense World
Robert W. Baird Cuts Mind Medicine (MindMed) (NASDAQ:MNMD) Price Target to $16.00 - Defense World
Mind Medicine (MindMed)’s (MNMD) Buy Rating Reiterated at HC Wainwright - Defense World
Mind Medicine’s (MNMD) Recent Achievements Boosting Stock - Markets Insider
Rhumbline Advisers Buys 4,868 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
Oppenheimer & Co. Inc. Grows Stock Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
Sanctuary Advisors LLC Lowers Stock Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
H.C. Wainwright maintains MindMed stock Buy rating, $55 target - Investing.com India
Mind Medicine’s Promising Future: Buy Rating Backed by Strong Phase 3 Prospects and Financial Position - TipRanks
Mind Medicine Inc (MNMD) Q4 2024 Earnings Call Highlights: Strat - GuruFocus.com
Mind Medicine Inc (MNMD) Q4 2024 Earnings Call Highlights: Strategic Advances and Financial ... - Yahoo Finance
MindMed Advances Clinical Trials and Strengthens Financial Position - TipRanks
Mind Medicine Getting An 'RFK Bump'? Retail Gets More Bullish As Stock Heads For Best Day In Over 10 Months - MSN
MindMed posts strong cash position, progress on LSD treatment - Green Market Report
Earnings call transcript: MindMed misses Q4 2024 EPS forecast, stock slides - Investing.com
Mind Medicine (MindMed) Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Mind Medicine (MindMed) Inc. SEC 10-K Report - TradingView
Mind Medicine reports Q4 EPS (41c), consensus (28c) - TipRanks
MIND MEDICINE Earnings Results: $MNMD Reports Quarterly Earnings - Nasdaq
Mind Medicine (MindMed) Inc. Loss At -$34.74 Mln In Q4 - Nasdaq
MindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Updates - Joplin Globe
MindMed to Present at Leerink’s Global Healthcare Conference 2025 - TipRanks
Can MindMed's Conference Appearance Signal New Brain Health Breakthroughs? - StockTitan
Learn to Evaluate (MNMD) using the Charts - Stock Traders Daily
Mind Medicine (MindMed) Inc. (MNMD): Among the Best Psychedelic Stocks to Buy in 2025 - Insider Monkey
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
12 Best Psychedelic Stocks to Buy in 2025 - Insider Monkey
Mind Medicine (MindMed) (MNMD) Projected to Post Earnings on Thursday - MarketBeat
Mind Medicine (MindMed) (MNMD) Expected to Announce Quarterly Earnings on Thursday - Defense World
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 5.3%Here's Why - MarketBeat
When the Price of (MNMD) Talks, People Listen - Stock Traders Daily
Can MindMed's 2024 Financial Results Reveal Its Brain Health Pipeline Progress? - StockTitan
Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 5.3%Time to Sell? - MarketBeat
Mind Medicine (MindMed) (MNMD) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap UpHere's What Happened - MarketBeat
Why Mind Medicine Stock Is Skyrocketing Today - MSN
OPNTMindMed Strengthens Board with Appointment of Two New Independent Directors - br.ADVFN.com
Mind Medicine (MNMD) Stock Surges on RFK Jr.'s HHS Confirmation - GuruFocus.com
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 9%Time to Sell? - MarketBeat
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Purchased by SG Americas Securities LLC - Defense World
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 5.5%Still a Buy? - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) Sees Strong Trading VolumeStill a Buy? - MarketBeat
Mind Medicine Inc Azioni (MNMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):